Showing results (731-740 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|December 2, 2008
Tumor suppressor gene inactivation in myeloid malignanciesJasmine C Wong, Michelle M Le Beau, Kevin ShannonBest Practice & Research. Clinical Haematology|December 2, 2008
Are new agents really making a difference in MDS?Richard M StoneBest Practice & Research. Clinical Haematology|December 2, 2008
Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapyElias J AnaissieBest Practice & Research. Clinical Haematology|December 2, 2008
What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?Claudio AnasettiBest Practice & Research. Clinical Haematology|September 16, 2008
Peptide vaccines for myeloid leukaemiasTao Dao, David A ScheinbergBest Practice & Research. Clinical Haematology|September 16, 2008
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz, Jeffrey S Miller, Michael R VernerisBest Practice & Research. Clinical Haematology|September 16, 2008
Cellular immunotherapy for multiple myelomaJacalyn Rosenblatt, David AviganBest Practice & Research. Clinical Haematology|December 7, 2013
Relapsed acute myeloid leukemia: why is there no standard of care?Farhad RavandiBest Practice & Research. Clinical Haematology|December 7, 2013
New agents: great expectations not realizedJeffrey E LancetBest Practice & Research. Clinical Haematology|December 7, 2013
Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemiaFrederick R AppelbaumPageof 113